论文部分内容阅读
抗血管生成化合药物———胞内抑制素和血管生成抑制素———在人体内的试验预定在今年晚些时候开始。这是据报道曾治愈小白鼠癌症的两种药物的结合疗法。血管生成即血管的形成。抗血管生成化合物能阻止微细血管的发育并切断肿瘤的生命线。研究的目的在于防止血管生成,使癌细胞
Anti-angiogenic drugs --- endostatin and angiostatin --- in the human test is scheduled to begin later this year. This is a combination therapy of two drugs reported to cure cancer in mice. Angiogenesis is the formation of blood vessels. Anti-angiogenic compounds prevent the development of fine blood vessels and cut off the tumor’s lifeline. The purpose of the study is to prevent angiogenesis and make cancer cells